The processes that take place during development and differentiation are directed through coordinated regulation of expression of a large number of genes. One such gene regulatory network provides cell cycle control in eukaryotic organisms. In this work, we have studied the structural features of the 5 H regulatory regions of cell cycle-related genes. We developed a new method for identifying composite substructures (modules) in regulatory regions of genes consisting of a binding site for a key transcription factor and additional contextual motifs: potential targets for other transcription factors that may synergistically regulate gene transcription. Applying this method to cell cycle-related promoters, we created a program for context-speci®c identi®cation of binding sites for transcription factors of the E2F family which are key regulators of the cell cycle. We found that E2F composite modules are found at a high frequency and in close proximity to the start of transcription in cell cycle-related promoters in comparison with other promoters. Using this information, we then searched for E2F sites in genomic sequences with the goal of identifying new genes which play important roles in controlling cell proliferation, differentiation and apoptosis. Using a chromatin immunoprecipitation assay, we then experimentally veri®ed the binding of E2F in vivo to the promoters predicted by the computer-assisted methods. Our identi®cation of new E2F target genes provides new insight into gene regulatory networks and provides a framework for continued analysis of the role of contextual promoter features in transcriptional regulation. The tools described are available at http:// compel.bionet.nsc.ru/FunSite/SiteScan.html.
The processes that take place during development and differentiation are directed through coordinated regulation of expression of a large number of genes. One such gene regulatory network provides cell cycle control in eukaryotic organisms. In this work, we have studied the structural features of the 5
H regulatory regions of cell cycle-related genes. We developed a new method for identifying composite substructures (modules) in regulatory regions of genes consisting of a binding site for a key transcription factor and additional contextual motifs: potential targets for other transcription factors that may synergistically regulate gene transcription. Applying this method to cell cycle-related promoters, we created a program for context-speci®c identi®cation of binding sites for transcription factors of the E2F family which are key regulators of the cell cycle. We found that E2F composite modules are found at a high frequency and in close proximity to the start of transcription in cell cycle-related promoters in comparison with other promoters. Using this information, we then searched for E2F sites in genomic sequences with the goal of identifying new genes which play important roles in controlling cell proliferation, differentiation and apoptosis. Using a chromatin immunoprecipitation assay, we then experimentally veri®ed the binding of E2F in vivo to the promoters predicted by the computer-assisted methods. Our identi®cation of new E2F target genes provides new insight into gene regulatory networks and provides a framework for continued analysis of the role of contextual promoter features in transcriptional regulation. The tools described are available at http:// compel.bionet.nsc.ru/FunSite/SiteScan.html.
Introduction
For the last one and a half decades bioinformatics has been used to study genomic regulatory sequences, ranging from short speci®c functional sites to extended control regions. The ultimate goal of this effort is to unravel the regulatory code, which is expected to provide a clue to how such a complex process as regulation of gene expression is encoded in the structure of promoter regions. Now that the complete nucleotide sequence of the human genome is about to be determined, bioinformatics approaches have become even more important. For example, genes whose products function in the same physiological or moleculargenetic process are often expressed coordinately. It is believed that this coordination is possible, at least in part, due to similarity in the structure of transcriptional regulatory regions of these genes, and primarily due to the presence of the binding sites for the same transcription factors. It is hoped that computer-assisted bioinformatics and experimental analysis of the human genome will provide new mechanisms for the identi®cation of elements which mediate a common transcriptional pro®le for a group of genes.
The genes responsible for progression through the cell cycle have always been in the spotlight, especially those essential for normal cell cycle pro-E-mail address of the corresponding author: ake@biobase.de gression in any cell type, the so-called cell cycle machinery. Both cell proliferation and the successful progression of the differentiation program depend on the correct, coordinated function of the genes in this group. Any malfunction in the operation of cell cycle-related genes can lead to uncontrolled proliferation and, eventually, to tumors. The E2F family of transcription factors has been implicated in the cell cycle-regulated expression of many cellular genes. 1 ± 6 E2F target genes include (1) genes that encode regulatory proteins comprising the so-called cell cycle machinery (cyclins, cyclin-dependent kinases, the E2F genes, the tumor suppressor RB1 genes); (2) some transcription factor genes of broad-spectrum (Myc and Myb families); (3) enzyme genes and genes of other protein components of the replication machinery; (4) some DNA repair genes; and (5) genes encoding structural proteins of chromatin (histones).
The E2F family comprises two subfamilies, E2F-1-E2F-6 and DP-1-DP-3, one member of each subgroup partnering to form an E2F/DP heterodimer (reviewed in 3 and 4 ) . The E2F genes and their products can be divided into three subgroups. (1) E2F-1-E2F-3, which display maximal expression in late G1-to early S-phase, 7, 8 are highly related; (2) E2F-4 and E2F-5 are less responsive to changes in proliferation and both proteins lack an N-terminal domain contained within E2Fs 1-3, and (3) E2F-6 is a recently cloned E2F family member that lacks both the N-terminal region of E2Fs 1-3 and the C-terminal region common to E2Fs 1-5. 9 The domain structure of the E2F transcription factors is well studied. The DNA-binding and dimerization domain is located closer to the N terminus of the molecule, and it was thought to be of the bHLH-ZIP (basic-Helix-Loop-Helix-Zipper) type. 10 However, a recent analysis of the crystal structure of the E2F4-DP2-DNA complexes suggested a WingedHelix DNA binding motif. 11 Important in the overall function of E2F activity is the interaction of E2F family members with other regulatory proteins. An acidic activation domain is located at the C terminus of E2Fs 1-5. 12 Situated within the activation domain are regions which mediate interaction of E2F family members with components of the general transcriptional machinery such as TBP, TFIIH, and CBP.
12 ± 14 A pRB-binding domain is also located within the transactivation domain. 12, 13 Because the E2F-1 activation domain cannot interact with positive regulatory factors such as TBP and negative regulatory factors such as pRB simultaneously, the retinoblastoma protein can inhibit the interaction between E2F-1 and the components of the basal complex, thereby repressing transcriptional activation by E2F-1. 13 Rb family members can also bind to histone deacetylases and thus it has been proposed that E2F/pocket complexes can mediate active repression of E2F target promoters by recruitment of histone deacetylases and subsequent alteration of chromatin structure which leads to transcriptional repression.
As noted above, the functions carried out by E2F sites depend in part on the protein spectrum of the complex assembled at these sites; this spectrum, in turn, is dependent on cell cycle stage (reviewed in 15 ). For example, E2F/pocket protein complexes are abundant in G0 and early G1 phase. It has been proposed that such complexes mediate transcriptional repression of E2F target genes (reviewed in 4 ). Transcriptional activation can be triggered by releasing E2F when pRB is phosphorylated by cyclin-cdk complexes which are activated as the cell cycle progresses (see 16 ± 19 ). Disruption of E2F/pocket complexes frees the E2F transactivation domain to interact with components of the transcriptional machinery. Finally, it is proposed that S phase-speci®c cyclin/cdks phosphorylate E2F/DP heterodimers, reducing their DNA binding ability 20, 21 and causing a reduction in transcription of E2F target genes. Thus, due to the action of both positive and negative regulatory proteins, the E2F/DP family is thought to cause variable expression at different stages of the cell cycle. Recent chromatin immunoprecipitation experiments have provided direct evidence in support of this model of E2F action for certain target genes. For example, B-myb 22 and cycA 23 promoters are bound by E2Fs and pocket proteins in G0 and G1 phase but the E2F site is not occupied in S phase. In contrast, other promoters, such as p107 23 retain E2F, but not pocket protein, binding in S phase and yet others, such as cdc2 and cycE 22 are bound by both E2Fs and pocket complexes throughout the cell cycle. Clearly, promoter context must determine exactly how, or if, a given promoter is regulated by E2F. 24 An understanding of the rules governing E2F-mediated regulation will be aided by the identi®cation and characterization of additional target promoters.
In the past few years, novel ideas concerned with identi®cation of target genes of transcription factors have been suggested by reports highlighting the combinatory nature of transcriptional regulation and the bene®ts of computer-aided analysis of the regulatory regions of functionally related gene groups (e.g. see a recent review 25 ). These efforts aimed at the identi®cation of muscle-speci®c promoters;
26 ± 29 the search of liver-speci®c gene promoters for potential HNF-1 sites; 30 the search for potential composite elements within promoters of immune response genes; 31 and the characterization of structural features of the CTF/NF-1 sites. 32 For example, potential sites were searched by using the weight matrix of the binding sites for HNF-1, a homeodomain-containing transcription factor with preferential expression in the liver. 30 About 100 potential binding sites for this factor have been found in the liver-speci®c gene promoters. As was shown, 95 % of oligonucleotides corresponding to these sites compete with a known site in the albumin gene promoter for binding to the proteins of a liver nuclear extract. 30 Although this is a strong indication for the usefulness of computerized site search methods, no warranty, however, is given that the revealed sites are indeed functional in the context of regulatory regions. The authors have studied the genomic distribution of potential HNF-1 sites and obtained several results: (1) these potential sites occur 2.5 times more frequent in liver-speci®c gene promoters than in random sequences; (2) most potential sites localize to the region between position À300 and the transcription start site; and (3) in liver-speci®c gene promoters, the potential binding sites, both those for HNF-1 and those for other factors, such as HNF-4, AP-1, Sp1, NF-Y, Oct, TBP are closely spaced. 30 The analysis of muscle-speci®c gene regulatory regions was performed by using weight matrices and a function of logistic regression. 28 Individual matrices were de®ned for transcription factor binding sites in many muscle-speci®c genes. These are the sites for muscle-speci®c transcription factors, such as MEF-2 and Myf, as well as for several ubiquitous factors such as Sp1, SRF, AP-1, and TEF. 28 The authors derived the matrices from data contained in the database Muscle-Speci®c Regulation of Transcription. The individual matrices were next combined into one recognition function. Thus a modular model of the muscle-speci®c type of promoters was developed, in which weight matrices were regarded as independent modules. The conclusion was drawn that``The speci®city of the modular approach results in meaningful prediction''. 28 A model of the promoter of a distinct class of muscle-speci®c genes, namely, actin genes, was developed by Werner and co-authors. 29 Promoters of 11 vertebrate actin genes were used as a training set. It has been demonstrated that the USF sites, the CCAAT box, SRF sites, Sp1 sites, the TATA box, and the Inr element are present in those promoters, in a speci®c order. 29 The yield of this model was 33 % false negatives versus one false positive per 1290 non-actin promoters in the EPD database. 29 We have previously developed a method for revealing new genes potentially regulated by composite NFAT/AP-1 elements. 31 This method comprises two weight matrices for the corresponding transcription factors (NFATp/c and AP-1). It considers the distance between two sites, their location relative to the transcription start site, and the presence of clusters of potential NFAT composite elements. The method permits us to discriminate T-cell-speci®c promoter sequences against other functional regions (coding and intron sequences) of the same genes, against promoters of musclespeci®c genes or against random sequences. Using this approach, a set of new potential target genes for NFAT/AP-1 complexes was identi®ed by scanning the EMBL data library. 31 Because of the high functional complexity of the cell cycle machinery and because the E2F transcription factors play a key role in regulation of the cell cycle-associated genes, the problem of identi®-cation of target genes for these factors is a major challenge. In this work, we have studied the structural features of the 5 H regulatory regions of cell cycle-related genes and made well-grounded predictions about a broad range of genes targeted by the E2F family members. Unlike many previous studies which have employed computer analysis to suggest potential binding sites, we have experimentally veri®ed the binding of E2F in vivo to the sites predicted by the computer-assisted methods. Our identi®cation of new E2F target genes provides new insight into gene regulatory networks and provides a framework for continued analysis of the role of promoter context in transcriptional regulation.
Results
Characterization of the E2F binding sites and the creation of the weight matrix Based on the information collected in the CYCLE-TRRD database (http://wwwmgs.bionet.nsc.ru/mgs/papers/kel_ov/celcyc/), we constructed a set of experimentally proven E2F binding sites that contains 45 sites within 33 different genes. In Table 1 , we describe the general characteristics of these sites and of the promoters of the corresponding genes. For example, we note that only a few (seven out of 33) E2F-regulated genes contain a TATA box. Also, as indicated in Table 1 , in many cases E2F sites are located within the ®rst 150 bp upstream of the transcription start site with some E2F sites, e.g. in the promoters of the p107, cdc6, orc1 and dhfr genes, actually overlapping the start site. However, in some cases the E2F sites are situated in the non-coding region of the ®rst exon or in the ®rst intron. As it is also evident from Table 1 , E2F-dependent genes often have two binding sites for the E2F factors. Such genes include e2f-1 of man, mouse, and quail; proto-oncogenes c-myc and N-myc; p107; cycE; EBNA1-nuclear antigen of the Epstein-Barr virus, and adenoviral EIIaE. In all these cases the E2F sites are situated in close proximity to each other, immediately adjacent or separated by 10-15 bp only. However, in the promoters of some genes E2F sites are separated by a greater distance. For instance, the E2F sites are separated by 30 bp in the cdc6 promoter, by 50 bp in the adenoviral gene E1A promoter, and by 85 bp in the human cdc2 promoter.
When inspecting E2F binding sites in the collection some structural features are immediately obvious. The conserved core sequence of the site is 12 bp in length, six base-pairs at the central positions consisting of the G and C nucleotides, and the¯anking sequences are enriched with the T and A Á nucleotides. The conserved CG nucleotide is in the center of all the sites (see Table 1 ). Most of these sites are symmetrical relative to CG and are either complementary palindromes, as in genes: N-myc, e2f-1, dhfr, PCNA; or mirror symmetric repeats as in gene p107. However, non-symmetrical sites will occur too, as, for instance, in the cycD1, cdc6, and cad genes. In some sites,¯anking sequences have very few AT nucleotides, such as for the proximal site of the cycE gene.
The generally accepted eight-letter consensus sequence of the E2F site, TTTSGCGC, was constructed on the basis of 12 sites in eight vertebrate genes. 33 The matrix so generated has accession number M00050 in the database TRANSFAC Release 3.5. 34 Furthermore, TRANSFAC also contains a E2F matrix (M00180) generated on the basis of data of eight sites, the consensus being written as GCGCGAAA, which corresponds to TTTCGCGC in the complementary strand. With 45 functional sites in 33 vertebrate genes, it is now possible to re®ne the weight matrix and extend the consensus. We constructed a weight matrix by aligning the 45 sites relative to the central CG dinucleotide ( Figure 1 ); all site sequences were taken on the coding strand of DNA. The matrix is most conserved where the GCGC tetranucleotide is, i.e. in the central positions of the site. A rather conserved trinucleotide, TTT, localizes to the 5 H region whereas the 3 H region is more degenerate (see Figure 1 ), although the prevalence of the nucleotide A is obvious. Based on the new weight matrix, the consensus sequence of the E2F site is TTTSGGCSMDR (Figure 1 ), according to the rules suggested. 35 
Accuracy of recognition of E2F binding sites by weight matrix
For recognition of the potential E2F binding sites we have applied a position weight matrix method as is described in the Data and Methods section. For evaluation of the method we constructed a weight matrix on the basis of sequences from the training set only (see the values in parentheses in Figure 1 ). The training set consists of 29 sites arbitrarily selected from the full data set (Table 1) .
A positive control set was used for assessing the accuracy of the method. The sites in the positive control set are presented in Tables 1 and 2 . Not included in the training set, these are blindly selected ten sites in vertebrate nuclear genes ( Table 1 , indicated by (ct)); six experimentally determined sites in the viral gene promoters ( Table 1 , sites No 40-45), and three sites in vertebrate genes that were not yet precisely mapped (Table 2 ). For instance, it has been demonstrated that the E2F factor is involved in the transcriptional regulation of the cdc7 gene, however, the region responsible for this regulation is quite long: À158/ 73. 36 We put into the positive control set the best match of the E2F matrix found in this region ( Table 2 , no. 2). Likewise, number 3 corresponds to the best match of the E2F matrix in the promoter region of the e2f-2 gene. Here, too, a long region that provides transcriptional regulation by the E2F factor was determined experimentally À151/ 169. 37 For recognition of potential binding sites within extended DNA sequences it is important to estimate how many false positive sites are captured by the method (level of overprediction errors). To estimate the level of overprediction errors we have used the set Ex2 as a negative sequence set consisting of sequences for second vertebrate exons (see Data and Methods). The minimal threshold that can be considered corresponds to the minimal score q obtained, that is 0.75 (see Table 1 ). At this threshold value the method has found 1757 sites in the Ex2 set. Let us assign this number to 100 %, and plot the number of sites found at other threshold values as the percentage of the number of sites found at the minimal threshold ( Figure 2 ). When the threshold is increased, the overprediction rate decreases. At q50.93 overprediction rate is equal to 0, which means that the method does not ®nd E2F sites with q50.93 in the Ex2 set.
When testing the positive control set at a cut-off value of 0.81, the method fails to correctly identify four sites of this set, which makes up 21 % (Table 3 ). In the c-myc promoter (Table 1 , site no. Figure 1 . Weight matrix and consensus for E2F binding sites. Values in the parentheses correspond to the weight matrix constructed using the 29 E2F sites in the training set (indicated by (t) in Table 1 ).
2), one of the two closely spaced E2F sites was included in the control set, but was not correctly identi®ed. The other site was included in the training set, and was correctly identi®ed with q0.87 ( Table 1 , site no. 1). It is likely that the two E2F sites in the c-myc gene promoter can function cooperatively, and the binding of the E2F factor to a low-af®nity site is stabilized due to the presence of a nearby high-af®nity site. At this cut-off value, the method also fails to recognize two closely spaced E2F sites in the EBNA1 gene of the Epstein-Barr virus and in the thymidine kinase gene promoter. At q50.86, six sites in the positive control set are not found, which makes up 31.6 %. Here, the rate of false positives is rather low, 0.153 per 1000 bp. At q50.93, nearly 60 % of the real sites (11 sites) have been missed. As one can see, the minimum of the sum of the levels of overprediction and underprediction errors is at the 0.86, and this value can be considered as conditional optimum (Figure 2) .
The threshold value can be selected arbitrarily depending on the purpose of sequence analysis (see Figure 2) . To reveal the majority of real sites, it is necessary to choose a low threshold value. For instance, according to the estimations about 15 % of real sites will be lost only at the low threshold level equal to 0.79, but more than 55 % of found sites will be false positives. On the other hand, if the task is to reveal the most reliable sites only, it is necessary to select a higher threshold. At threshold value 0.93 or above the percentage of false positives is expected to be quite low (see above), but as much as 60 % of the real sites will not be recognized by the method. It becomes clear that additional criteria are needed to decrease false positive rate without losing too many real sites.
Analysis of additional sequence motifs in the context of E2F sites
To investigate whether there are preferred sequence motifs in the context of E2F binding sites we have created two sets of sequences: set Y and set N (see Data and Methods). The set Y consists of extended E2F sites corresponding to those in the training set (indicated by (t) in Table 1 ). The length of each sequence was L 72 bp (the E2F site comprising 12 bp in the center and¯anking sequences 30 bp on either side). The set N consists of 100 sequences of the same length L 72 bp taken from the set Ex2 so that in the center of each sequence a false positive match of the E2F matrix with the score value q50.80 is detected. We performed an exhaustive search for contextual motifs that distinguish the Y and N sets, as described in Data and Methods. More than 10 8 characteristics ((l,w)-combinations) have been checked. Among them, about 10 3 characteristics have the utility value U(l,w) > 0.7. Each of these characteristics (speci®c motif l in window w) exhibits a statistically signi®-cant difference between sets Y and N. Eleven mutually uncorrelated characteristics have been selected (Table 4) .
On the basis of these 11 characteristics (m 11) we constructed the linear classi®cation function discriminating sets Y and N by means of linear discriminant analysis. For any sequence X of the length L 72 bp we compute the score value:
where a i and b are the coef®cients of the discriminating function (see Table 4 ). We refer to function (1) as E2F score of context. Among selected 11 motifs, the ®rst six are characterized by an elevated frequency in thē anking sequences of E2F sites in comparison with the sequences from the set of exons 2 (positive characteristics), whereas the last ®ve motifs are characterized by a reduced frequency (negative characteristics). The corresponding windows where the selected motifs were found to be overrepresented/underrepresented are rather different in their length and location. For instance, windows for motifs no. 3 and 5 are located in the 5
H¯a nking regions relative to the E2F sites; windows for motifs no. 4, 6, 7, 8 and 11 cover long regions including E2F sites; windows for motifs no. 2, 9 and 10 overlap with the 5 H end of the E2F sites. It is interesting to observe that motif no. 1 (TTT) is found to be overrepresented in the small window locating at the 3 H half of E2F sites. Such motifs are context-speci®c for some of known non-symmetrical E2F sites that are hardly to be recognized by the weight matrix. It is clear that the found motifs bring additional information about the ®ne structure and context features of E2F sites in promoters of cell cycle-speci®c genes.
The advantage of the score of context d (equation (2)) as an additional ®lter to identify potential E2F is demonstrated in Figure 3 . As a ®rst step we identify the potential E2F sites by using the weight matrix with de®nite cut-off values q cut-off . Then, we apply the d score to an extended region surrounding each potential E2F site. The requirement d > 0 (d cut-off 0.0) is used as an additional argument for recognition of E2F sites.
Running the method with gradually increasing q cut-off for the sequences from positive control set and negative control set, and plotting the false positive (FP) versus false negatives (FN) rates, it becomes evident that taking the context motifs into account provides a signi®cant decrease of false positive rate (Figure 3(a) ). With the high q cut-off values of the weight matrix (0.80 and more) the sequential application of the d score (named in the Figure as PWM score of context) decreases the false positive rate more than tenfold (Figure 3(a) ), leaving the false negative rate practically unchanged (Figure 3(b) ). When using a low weight matrix cut-off (q cut-off is less than 0.80) the PWM score of context method is characterized by comparatively high rate of false negatives (about 21 %) (see Figure 3(b) ). Therefore, the score of context appeared reasonable to be applied for revealing Table 4 . Eleven uncorrelated characteristics found in the context of E2F sites in promoters of C-genes high scoring E2F sites. To search for all potential E2F sites it is necessary to use the conventional weight matrix method with a low cut-off value. The price of high false positive rate has to be paid therewithal.
Promoters of cell cycle genes are significantly enriched by potential E2F binding sites
We have compared the frequencies of potential E2F binding sites within the promoters of cell cycle genes with the frequencies in promoter regions of functionally different genes. In addition, three types of random sequences and a set of vertebrate second exons were used for comparative analysis. The sets analyzed were: promoters of cell cycle genes (C-prom), promoters of muscle-speci®c genes (M-prom), promoters of genes induced upon immune response (T-prom), promoters collected in the Eukaryotic Promoter Database (EPD-prom).
(Only a limited number of cell cycle related genes are presented in EPD. These are dhfr, tk and some histone genes. Many genes encoding components of the cell cycle machinery are not included in EPD release 56.) Detailed characteristics of these sets are given in Table 9 (see Data and Methods).
We scanned these sequences by the developed PWM for E2F sites. The score of context was not applied on this step. Frequencies of found potential E2F binding sites for different threshold values are shown in Figure 4 . E2F frequency is signi®cantly higher in the set C-prom than in all other sets at any threshold value. Random sequences with the same mononucleotide and dinucleotide distribution as in the C-prom set (Figure 4 , curve rand-C, and di-rand C) exhibit slightly elevated frequency of potential E2F sites, but still signi®-cantly lower than C-prom. Apparently, the frequencies of mono-and dinucleotides are correlated with the E2F binding site occurrence but cannot completely de®ne it.
The high concentration of E2F sites in the C-prom set could not be explained simply by known sites which are present in the sequences analyzed. We found in the C-prom set 302 potential E2F sites with score values higher than 0.75. Only 36 of them are known and experimentally veri®ed (presented in the Table 1 ). Others are new and found in all sequences of the set with high concentration.
Thus, the frequencies of potential E2F binding sites vary signi®cantly between different DNA sequences. The results obtained suggest that promoters of cell cycle-related genes are signi®cantly enriched by both high scoring and low scoring potential E2F binding sites. Therefore, the frequency of the potential E2F binding sites can be effectively used for functional classi®cation of the promoters.
Location of E2F sites relative to the transcription start site
As can be seen from Table 1 , the majority of the experimentally proven E2F sites are located immediately near the transcription start site. We . The ordinate axis gives the frequency of potential E2F sites per 1 bp. E2F frequency is signi®cantly higher in the set C-prom than in all other sets at any threshold value. The lowest E2F frequencies occur within promoters of muscle-speci®c genes, second exons and promoters of genes induced upon immune response (5 to 20 times lower than in the random sequences with the even nucleotide distribution rand-0.25). E2F frequency in the set EPD-prom is similar to that in the random sequences rand-0.25. Random sequences with the same mononucleotide and dinucleotide distribution as in the C-prom set (curve rand-C, and di-rand C) exhibit slightly elevated frequency of potential E2F sites, but still signi®cantly lower than C-prom.
wanted to investigate if this holds true for potential sites in the genes with variable expression throughout the cell cycle. The C-and EPD-gene promoters were divided into 50 bp segments. The frequency of potential E2F sites was counted for each of such regions, as shown in the histogram ( Figure 5 ). As can be seen, in the C-gene promoters, potential E2F sites localize close to the transcription start site. Their concentration has a distinct peak between positions À50 and 1 relative to the transcription start site (Figure 5 ).
In the EPD-gene promoters, potential E2F sites are evenly distributed over the entire length, with no peaks observed ( Figure 5 ). Over a long region spanning from À400 to 100, the E2F sites in the C-gene promoters occur more frequently than in the EPD promoters. The respective concentrations of potential E2F sites upstream of position À400 are indistinguishable in these two groups of promoters, thereby suggesting that functional E2F sites are most unlikely to occur in this region ( Figure 5) .
Thus, the study of the distribution of the potential E2F sites suggests that they localize close to the transcription start site, between positions À400 and 150. The concentration is distinctly peaking over the ®rst 50 nucleotides upstream of the transcription start site.
Eligibility criteria for searching of new potential E2F target genes
Based on the results of testing the E2F site recognition method on the control sets and comparisons of frequency of potential E2F sites in C-gene promoters and in other sequences, we came up with the following criteria for identi®cation of new genes targeted by E2F family members. For every gene with known location of transcription start site:
(1) Search for potential E2F sites is performed in three modes: (i) q cut-off 0.86 (relaxed mode); (ii) q cut-off 0.80 and d cut-off 0.0 (moderate mode); (iii) q cut-off 0.80 and d cut-off 1.9 (stringent mode).
(2) At least one potential E2F site should be found between positions À400 to 150 relative to the transcription start site.
Using these criteria, for a selected searching mode, we now can identify genes as potential E2F targets in different phases of the cell cycle. If within the same promoter additional sites are found with q between 0.80 and 0.86, these are also assumed to be potential E2F sites.
We have tested the three modes of eligibility criteria on several sets of sequences (see Table 5 ).
One can see that the stringent mode of searching criteria is characterized by rather low level of false positive rate (1.4 %) and by reasonably high true positive rate (about 65 % ). This mode is quite effective in ®ltering false positives as it is shown in the Table 5 on the example of muscle-speci®c and immune cell-speci®c promoters. We used the stringent mode for scanning the EMBL database (see below) to prevent the results from being diluted by too many false positives. The relaxed mode of searching criteria provides better true positive rate (80 %), that makes it useful for careful analysis of small sets of genes. The high level of false positives (8.5 %) prevents us from using this mode for database screening.
Scanning EMBL for E2F target genes
To reveal new E2F target genes we scanned EMBL release 6.0, divisions: hum, rod, vrt, and mam. We selected automatically from EMBL all entries that contain clear information about promoter position. For that we applied keyword search a Sequences from the Ex2 set (see Table 9 ) were concatenated and then chopped into pieces of 550 bp length. b TP, Estimation of the true positive rate on the whole set of known cell cycle-related genes; FP, estimation of the false positive rate on the set of exon2 sequences (the number of 550 bp pieces of exon 2 sequences that were identi®es as potential E2F targets). in the FT ®elds. We checked for keywords: (``prim_transcript'') or (``precursor_RNA'') or (``mRNA'' and``join'' but not``:``).
4459 promoter sequences were selected from EMBL (Table 6 ). It is known that retrieving promoters from EMBL by the use of such a keyword search is far from completeness. Therefore, in addition to the automatic retrieving of promoters we have collected manually all available promoters for cell cycle-related genes by the help of detailed analysis of EMBL feature tables as well as by the use of information from the EPD database and from various literature sources. We have retrieved additionally 152 promoters that were missed by automatic EMBL feature table search. All 4611 promoters have been analyzed with the use of stringent criteria: search for E2F sites in the region [ À400, 150], with cut-off value q cut-off 0.80 and with applying the score of context d > 1.9.
As a result, 342 promoters were identi®ed as potential E2F targets. Among the corresponding genes, 29 are known E2F-dependent genes, and 313 new potential E2F target genes. In Table 6 we show the distribution of the found target genes among different gene functional groups. The Table with potential E2F target genes that are found in the current release of EMBL is available by request.
One can see that besides the known E2F regulated gene functional groups we propose new E2F target genes in such important groups of genes as: nucleolins, prions, ribosomal proteins and rRNA genes, several genes for receptors and transporters as well as genes for several heat shock proteins.
Phylogenetic footprinting as an additional argument for the identification of E2F binding sites
Phylogenetic footprinting is a method based on the assumption that the parts of gene regulatory regions that are liable to no or little variations in the course of evolution have important functions. 38 The essence of the method is the alignment of the regulatory regions of the orthologous genes and ®nding of the most highly conserved regions. To this end, we took advantage of phylogenetic footprinting as an additional criterion for the assertion of the potential regulatory elements, in our case, the E2F transcription factor binding sites. The alignment was done with ClustalX.
We found that in many cases, potential E2F binding sites are conserved across species. For instance, the site at À300 in the promoters of human and mouse tgf-b1 genes (CTTCGCGCCCTGG, q 0.91). Promoters of the human and mouse mcm4 genes contain three conserved sites, at À24 (TGTCGCGCAGGT, q 0.85); at À329 (AGTGGCGCCTCC, q 0.81); and at À443 (TTTCCCGCGAAA, q 0.87). In the promoter of c-fos proto-oncogene, the predicted E2F site around À420 (TTTCCCGCCTCC, q 0.84), is absolutely conserved between rodents: mouse, rat, and hamster. The corresponding site in the human gene contains one mismatch that makes q < 0.80. In addition, we have revealed three potential binding sites in the human c-fos proximal promoter, q 0.91, 0.84, 0.87, that are not conserved in rodents.
We have demonstrated the presence of potential E2F sites in the promoters of nucleolin genes of four mammalian species. Potential E2F sites, most Identi®cation of E2F Target Genes similar to the consensus (q 0.96 and 0.97), are homologous in humans and rodents ( Figure 6) . In all the rodent species considered (mouse, rat, hamster), these sites are absolutely conserved, while in man, three substitutions occur. Additionally, we revealed potential E2F sites with little similarity to the consensus (q 0.76-0.81) and no homology in different species ( Figure 6 ). It is tempting to propose a role for E2F in the regulation of nucleolin genes. We decided to con®rm this by determining if E2F factors bind to the human, hamster, and mouse nucleolin promoters.
Confirming E2F targets by chromatin immunoprecipitation
One method for con®rming that E2F family members regulate speci®c promoters has been to test the ability of E2Fs to bind in vitro to the promoter-speci®c oligonucleotides. However, such in vitro studies may lead to false conclusions due to the arti®cial nature of the analysis. For example, promoter context cannot contribute to binding when an isolated site is studied and the inclusion of a single site, in the absence of competition with the rest of the genome, may not provide an accurate view of the in vivo situation. Therefore, experimental veri®cation of the binding of E2F to the identi®ed sites should be performed under normal physiological conditions. The study of E2F binding in living cells has recently been demonstrated using an in vivo formaldehyde cross-linking technique. 22, 23, 39 Brie¯y, this protocol involves treating cells with formaldehyde to cross-link the transcription complexes to promoter DNA and immunoprecipitation of the protein-DNA complexes with an antibody against an individual E2F followed by analysis of the immunoprecipitated DNA by PCR using promoter-speci®c primers. This method has been successfully applied to study in vivo binding of different E2F family members to genes which were previously shown to be regulated by the E2F family using in vitro techniques. To date, in vivo E2F binding has been con®rmed at the e2f-1, cdc6, cdc25A, p107, B-myb, cdc2, dhfr, thymidine kinase, cycE and cycA promoters. 22, 23 We have now used the method of chromatin immunoprecipitation to determine if E2F-4 binds to the promoter regions of the human, mouse, and hamster nucleolin genes. The results shown in Figure 6 . Phylogenetic footprinting as an additional criterion for recognition of potential E2F binding sites. Conserved potential E2F sites in the promoters of the mammalian nucleolin gene. Figure 7 clearly provide a strong positive con®r-mation for the functional signi®cance of the predicted E2F sites within the orthologous nucleolin gene promoters.
We have also used the in vivo formaldehyde cross-linking technique to con®rm the identity of other potential E2F target genes that have been suggested computationally. We have used HeLa cells for these experiments since all six E2Fs are present in these cells. For experimental analysis, we have chosen several computationally predicted target genes whose possible transcriptional regulation by E2F family members is considered to be interesting taking into account known functions of those genes. Those selected include c-fos and junB; members of the AP-1 family of transcription factors; the gene encoding TGF-b which acts as an antiproliferative agent to a majority of cell types; ARF locus encoding protein that binds to and stabilizes p53 and thus functions in tumor suppression; mcm4 and mcm5 involved in the initiation of DNA replication; von Hippel-Lindau (VHL) tumor suppressor gene; and e2f-1 (see Table 7 ). Each of the promoters tested in Figure 8 have been analyzed using the exact same immunoprecipitated samples, allowing us to directly compare the binding of E2F family members to the different promoters. As a positive control, we have examined in vivo E2F binding to the dhfr promoter. Regulation of the dhfr promoter by the E2F family has been demonstrated using several different methods and binding of E2Fs to the dhfr promoter has been shown both in vitro and in vivo.
14,22,40 ± 43 As a negative control, we used the 3 H -end of the dhfr gene that is known to have no E2F binding sites. 22 À`n o antibody'' control was also included in each experiment and the small signal in this lane was subtracted from each of the signals before the percentage relative to input was calculated. As expected, we found that several of the E2Fs bound to the dhfr promoter (Figure 8(a) ). In contrast, very little E2F binding was detected at the 3 H end of the dhfr gene (Figure 8(b) ). Thus, the control demonstrates the speci®city of the experimental protocol.
Using antibodies against various members of the E2F family, we have con®rmed speci®c E2F binding to all promoters under study in asynchronously growing HeLa cells (Figure 8(c) ). By reporting signal intensity relative to a ®xed portion of input, we can directly compare binding of the E2Fs at the different promoters. In general, the signal intensities relative to input suggest that all of the computer-identi®ed promoters bind E2Fs at approximately the same level, as does the dhfr promoter. However, binding of E2Fs to the mcm4 and mcm5 promoters appears to be stronger than to the other promoters. For all investigated promoters, including dhfr, practically no E2F-5 binding was shown, which coincides with previous data obtained using human T98G cells and mouse 3T3 cells. 23 For all promoters except e2f-1, we also observed low signals using an antibody against E2F-3. However, we have found that E2F-3 signal intensities are the most variable between experiments (data not shown). Signals using E2F-1, E2F-2, and E2F-4 antibodies are the most intense; in most cases the signals are about 60-150 % relative to the input. Previous studies have not examined binding of E2F-6 to cellular promoters. However, E2F-6 is a special member of the E2F family, as this is a repressor lacking both the activation domain and pocket-interaction domain. 9 Although its function in vivo is not clear, evidence to date suggests that E2F6 may be a negative regulator of transcription. Interestingly, we ®nd that although most of the promoters show considerable E2F-6 binding (relative to the other E2Fs), the dhfr, mcm4, and mcm5 promoters have very low E2F-6 signals. The binding of several different E2Fs to an E2F target gene could be due to (1) the existence of multiple E2Fs within the promoter region (see Table 7 ), (2) diffferential binding of speci®c E2Fs in different stages of the cell cycle, 22, 23 or (3) the stochastic nature of transcription complex formation (see 22 for further details). Although E2F binding to eight different mammalian promoters containing computationally predicted target sites was con®rmed by in vivo chromatin immunoprecipitations, de®nition of the characteristics of E2F binding sites that correlate with the preferential binding of distinct E2F family members requires additional theoretical and experimental investigations.
It is interesting to note that for all E2F target genes which have been con®rmed by chromatin immunoprecipitation we have revealed at least one site that is conserved between mammalian species. Thus, phylogenetic footprinting may serve as an additional criterion for the identi®cation of functional sites in newly sequenced regulatory regions. If the results of the computerized search for the Figure 7 . Experimental veri®cation of the nucleolin promoter as an E2F target. Crosslinked chromatin from human (HeLa cells), mouse (adult mouse liver), and hamster (chinese hamster ovary cells) samples was incubated with an antibody to E2F4 or in the absence of antibody (No Ab). Immunoprecipitates were analyzed by PCR using primers speci®c for the nucleolin promoter from each species. The nucleolin promoter is clearly present in the sample prepared using an E2F4 antibody but is not present in the control immunoprecipitate. a In the cases when multiple starts of transcription are known (HSTGFB1PR, AF082338) an extended promoter region (up to À1500 bp) has been searched for E2F sites.
b Positive values of the score of context are shown only. At least one E2F site with the positive score of context is found in the promoter regions of these genes. Figure 8 . In vivo formaldehyde cross-linking experiments con®rming potential E2F target genes that have been suggested computationally. Shown is an analysis of E2F binding to the different promoters in asynchronously growing HeLa cells. Cross-linked chromatin from these cells was incubated with antibodies to E2F1-6 or in the absence of antibody. Immunoprecipitates from each sample were analyzed by PCR using primers speci®c for the different promoters. As a control, a sample representing a ®xed percentage of the input chromatin was included. For each set of primers, the signal in the``no antibody'' reaction was subtracted from the signals in the E2F reactions. The E2F signals are then reported as a percentage of input. This allows the different promoters to be compared, regardless of PCR ef®ciencies.
E2F sites at a suf®ciently high value of q cut-off are consistent with phylogenetic footprinting data, it is more likely that the sites we have revealed are indeed functional. However, based solely on this method, we cannot deliberately``sort out'' sites, because in different species real functional sites may not be con®ned to homologous regions.
Discussion
This work is a combined effort of theoretical and experimental approaches to study transcriptional regulation of genes by the E2F family of transcription factors. Because E2F factors regulate a number of genes involved in proliferation control and S phase entry, we reasoned that identi®cation of other genes regulated by the E2F family would provide insight into cell proliferation. From the earlier published data on transcriptional regulation of cell cycle-related genes contained in CYCLE-TRRD 44 and TRANSFAC, 34 we generated a largesample set of E2F binding sites and derived the corresponding weight matrix. Based on the matrix, we developed a computer method for searching regulatory regions for E2F binding sites. Using the criteria listed above, we have identi®ed a large number of new genes that could be regulated by E2F transcription factors (see Table 6 ). One category of identi®ed genes includes orthologs of genes that were previously known to be regulated by E2F family members. For example, the human cycD1 and RB1 promoters were previously reported to be regulated by E2F and we have now identi®ed E2F sites in the rat cycD1 and the mouse RB1 promoters. However, most of the genes which we have identi®ed have not been suggested previously to be E2F target genes in any mammalian species. The identi®ed E2F target genes can be classi®ed into large groups, depending on the function of the proteins they encode. For example, we identi®ed cell cycle-related genes such as E2F transcription factors, cyclins, cyclin-dependent kinases and phosphatases, inhibitors of cyclin-dependent kinases, RB1, p53, and ARF; factors and enzymes involved in DNA replication, DNA repair, and nucleotide metabolism; histone genes, transcription factors of the Myc, Myb, and AP-1 families, nucleolins, RNA polymerases, and genes encoding components of signal transduction pathways (see Table 6 ).
Identification and classification of genes potentially regulated by E2F
Although the expression of most E2F-dependent genes (such as dhfr, e2f-1, RB1, and p107) peaks at the G1/S boundary, E2F factors are also involved in regulating genes that control other phases of the cell cycle. For example, there are several E2F-regulated genes, such as cycA, cdc2, and certain histone genes, whose expression remains high throughout S-phase and into G2 phase. To date, regulation by E2F factors has been demonstrated experimentally only for two histone genes. Our results suggest that E2F may be involved in the control of many more types of histone genes than previously demonstrated. We have also identi®ed potential E2F sites in G2-speci®c genes such as cycB1, cdc25C, and plk. It has been demonstrated elsewhere that G2-speci®c transcription of several genes is mediated by two closely spaced CDE (C/G GCGG) and CHR (TTGAA) cis-elements, to which yet unidenti®ed proteins bind that suppress transcription at the earlier stages of the cell cycle. 45, 46 Our results suggest that the E2F family members contribute to G2-speci®c expression along with the factors interacting with CDE and CHR. This assumption is in a good agreement with the recently established view that E2F-mediated repression is one of the most frequent ways of exerting transcriptional regulation on the genes. 46, 47 We predicted theoretically and veri®ed experimentally the binding of the factors of the E2F family in vivo to the promoters of genes encoding the proteins of the AP-1 family. These genes are highly inducible at G0/G1 transition. AP-1 family members are known to activate transcription of cyclins and cdks 48 that in turn activate E2F factors through retinoblastoma phosphorylation. Our results suggest positive feedback from the E2F factors to the fos and jun genes. Our computer analysis also revealed potential E2F sites in genes encoding various other components of signal transduction pathways, such as ERK-1, Ras and RanBP1. This suggests other possible positive feedback loops from E2Fs to upstream components of signal transduction pathways. In normal cells, however, the expression of the jun, fos, erk and ras genes does not depend on cell cycle stage as critically as does the expression of other E2F target genes. We propose that E2F-dependent regulation of certain genes takes place in unique situations, for instance, during uncontrolled cell proliferation, when the levels and activity of the E2F factors exceed a certain threshold. Another interesting group of genes potentially regulated by E2F has maximal expression in quiescent cells (G0 stage). These are inhibitors of cyclin-dependent kinases and TGF-b. Therefore, although the identi®cation of an E2F target gene predicts cell cycle regulation, the exact pattern of gene expression must be determined experimentally.
We suggest that the computer-assisted identi®-cation of E2F target genes can be used in two different ways to simplify future studies of transcriptional regulation. First, if a gene is known to be cell cycle-regulated, a sequence analysis using the criteria described here could be used to determine if the cell cycle regulation is mediated by E2F. For example, we have proposed, based on computer prediction, phylogenetic conservation, and in vivo binding studies, that E2F is involved in the control of nucleolin gene transcription. Others have demonstrated that expression of nucleolin is low in serum-starved cells and high in S phase. 49 Based on our studies, it is likely that this S phasespeci®c regulation is mediated through the conserved E2F binding sites in the nucleolin promoter. Thus, identi®cation of nucleolin as an E2F target has greatly simpli®ed future studies of the transcriptional regulation of this gene. A second way in which our computer-assisted identi®cation can be useful is in the ability to identify additional genes that are cell cycle regulated. As shown in Figure 4 , E2F sites are found at a higher frequency in the promoters of cell cycle-related genes than in other DNA sequences. At q cut-off = 0.86 (incidentally, this is the value at which the sum of false negatives and false positives is minimal), the potential E2F sites occur in the promoters of the cell cycle-related genes 3.5 times more frequently than in random sequences, and ten times more frequently than in promoters of muscle-speci®c and immune response genes (Figure 4) . Thus, our results suggest that the frequency of potential E2F sites in promoter regions can be a reliable criterion for the identi®cation of cell cycle-regulated genes.
A hypothesis of promoter-defining sites
Functionally related genes involved in the same molecular-genetic, biochemical, or physiological process are often regulated coordinately by members of families of closely related factors. We use the term``promoter-de®ning sites'' to refer to binding sites which are responsible for the common structural features of promoters in functionally related genes and which are also responsible for a large component of the common pattern of gene expression. Based on the results reported herein and elsewhere, some features of promoter-de®ning sites in functionally related groups of genes can be identi®ed:
(1) The promoter-de®ning sites are revealed in speci®c promoters with a frequency signi®cantly higher than in random sequences. This holds true both for sites similar to the consensus (at high cutoff values), and for sites with little similarity to it (at low cut-off values). Other investigators demonstrated that the frequency of potential HNF-1 sites is 2.5 times higher in liver-speci®c gene promoters than in random sequences. 30 The frequency of the potential composite elements NFAT/AP-1 is ten times higher in the promoters of immune response genes than in random sequences. 31 In this work we have demonstrated it in detail for E2F binding sites ( Figure 4) . (2) The frequency of promoter-de®ning sites signi®cantly differs between the promoters of the genes belonging to different functional groups, which can be used as a criterion for functional classi®cation of the promoters. A comparison of the frequencies of E2F sites and of composite elements NFAT/AP-1 in four groups of promoters is presented in Table 8 . For the purposes of this comparison, the cut-off values were chosen such that the number of false positives in the random sequences was the same for the E2F sites and the composite elements NFAT/AP-1. As can be seen, the E2F binding sites are 28 times more frequent in the cell cycle gene promoters than in musclespeci®c gene promoters; seven times more frequent than in EPD promoters; while in the promoters of the immune response genes, recognition of the E2F sites at this cut-off value fails (Table 8 see also Figure 4 in Results). The frequency of ®nding the composite elements NFAT/AP-1 looks different. In the promoters of immune response genes, they are 4.5 times more frequent than in those of cell cyclerelated genes, and 2.5 times more frequent than in muscle-speci®c or EPD promoters (Table 8) .
(3) Promoter-de®ning sites are located close to the transcription start site. The composite elements NFAT/AP-1 largely localize to the ®rst 300 bp upstream of the transcription start site. 31 Likewise, in the promoters of liver-speci®c genes, most HNF-1 sites localize to the region between À300 bp and the transcription start site. 30 The study of the distribution of the potential E2F sites relative to the transcription start site demonstrated that they are largely located in the region between À400 and 100 ( Figure 5) . A distinct peak of concentration of the E2F sites is observed between À50 and 1 ( Figure 5 ). This localization is consistent with data on the mechanisms of E2F function and on the structure of basal promoters of the genes regulated by E2F factors. Few E2F target promoters contain a TATA box ( Table 1 ), suggesting that E2F may function in place of direct binding of TBP to promoter DNA. It is known that E2F-1 is capable, through its activation domain, of interacting with the basal complex components, namely TBP and the general factor TFIIH 13, 50 . Recently, evidence of cooperative interactions between E2F and the basal transcription factors TFIIA and TFIID was also obtained. The entirety of these facts and the proximity of the potential E2F sites to the transcription start suggest that E2F factors may be involved in transcriptional regulation as early as at the stage of basal complex assembly, providing the recruitment of TBP to TATA-less promoters and additionally stabilizing TBP binding to TATA-containing promoters.. In the cases considered here, we successfully classi®ed E2F target promoters by looking at just one type of site. However, it is clear that promoter context can be very important in determining regulation by a transcription factor. An analysis of thē anking sequences of the E2F sites in the promoters of cell cycle-related genes allowed us to reveal speci®c motifs which occur in certain segments of these sequences at reliably higher frequency than in the Ex2 set. With these motifs, we developed an additional test for checking out the context surrounding the potential E2F sites. This test allowed us to considerably reduce the number of sites incorrectly identi®ed as being E2F binding sites. It may well be that these motifs serve as binding sites for various transcription co-factors. Apparently, this structure of the¯anking sequences re¯ects a possible cooperation in the relationships between the E2F factors and other factors during regulatory complex assembly. Future studies of such cooperation mechanisms of regulation of cell cycle-related genes are clearly required.
In summary, the computer method presented here allows us to systematically reveal promoters likely to be recognized by the factors of the E2F family. A comparison of the binding of E2F factors in vivo with the sites predicted in the promoters of 11 genes con®rms the recognition of these promoters by E2F factors and provides a convincing demonstration that performing theoretical and experimental studies in combination is very instrumental in analyzing the regulatory regions of genes. With the advent of the large-scale sequencing projects, it is becoming increasingly essential that computational biologists team up with bench-scientists in order to develop a detailed understanding of the transcriptional networks that control mammalian cell growth and development. 25, 52, 53 Data and Methods
Sets of sequences used for analysis of E2F sites
The sets of sequences that were used in the analysis are given in Table 9 . The set designated C-prom includes promoters of genes that are known to be controlled by E2F transcription factors. Orthologs of these genes from other vertebrate species (if the promoter sequence is available in EMBL rel.58) are included in this set as well. The set EPD-prom includes promoters of vertebrates from EPD rel. 56 (Eukaryotic Promoter Database). Additionally we use promoter sets of genes expressed in muscle tissue (M-prom) and in immune cells (T-prom). 31 Random sequences were generated to estimate how often potential binding sites can appear just by chance. The set rand-0.25 contains computer-generated random sequences with equal frequencies for the four nucleotides. We used it for estimation of the basic false positive rate of the recognition method. Random sequences with nucleotide and dinucleotide frequencies corresponding to that within C-prom were generated as well and used where indicated (see Results) (sets: rand-C and di-rand-C).
Set Ex2 contains 4051 sequences of the second exons of vertebrate genes (based on EMBL rel. 48). This set is available on the TRANSFAC server and was designed previously. 54 Up to now, only very few functionally relevant binding sites have been revealed experimentally in second exons, therefore the potential binding sites found in these sequences may be considered a priori as false positives.
Weight matrix method for recognition of E2F sites
The weight matrix method is used to search for potential E2F sites in any nucleotide sequence. A sliding window moves through the sequence and a score value is calculated for every position of the window. For calculating the score q we used an approach implying an information vector 55, 56 antibody reaction for each time point was saved as total input chromatin and was processed with the eluted immunoprecipitates beginning at the crosslink reversal step. Crosslinks were reversed by addition of NaCl to a ®nal concentration of 200 mM and RNA was removed by addition of 10 mg RNase A per sample followed by incubation at 65 C for ®ve hours. Samples were then precipitated at À20 C overnight by the addition of two volumes of EtOH and then pelleted by microcentrifugation. Samples were resusupended in 100 ml TE (pH 7.5), 25 ml of 5Â proteinase K buffer (1.25 % SDS, 50 mM Tris (pH 7.5), 25 mM EDTA), and 1.5 ml of proteinase K (Boehringer Mannheim) and incubated at 45 C for two hours. Samples were extracted with phenol: chloroform: isoamyl alcohol (25:24:1, by vol.) and then precipitated with 0.1 volume of 3 M NaOAc (pH 5.3), 5 mg tRNA, and two volumes of EtOH at À20 C overnight. Pellets were collected by microcentrifugation, resuspended in 30 ml water, and analyzed using PCR.
PCR reactions contained 2 ml of immunoprecipitate or 2 ul of a 1:100 dilution of the total sample, 50 ng of each primer, 0.88 mM MgCl 2 , 2 mM each dATP, dCTP, dGTP, dTTP, 1Â Thermophilic Buffer (Promega), and 1.25 units Taq DNA polymerase (Promega) in a total volume of 20 ml. Following 32-35 cycles of ampli®cation, PCR products were run on a 1.5 % (w/v) agarose gel and analyzed by EtBr staining. PCR primers used to analyze target genes are shown in Table 10 . An annealing temperature of 60 C was used for all primer pairs except for the hE2F1 primers which required an annealing temperature of 68 C and the nucleolin primer sets which all require an annealing temperature of 57 C. 
